Immunogenicity:-:-: FDA package insert:Nar:

Preferred Label : Immunogenicity:-:-: FDA package insert:Nar:;

LOINC status : ACTIVE;

LOINC long common name : FDA package insert Immunogenicity;

LOINC short name : FDA insert Immunogenicity;

LOINC description : This subsection, which is contained in the Adverse Reactions section, describes the product's potential ability to trigger an immune response, according to the Physical Labeling Rule format. [https://www.fda.gov/OHRMS/DOCKETS/98fr/06-545.pdf];

Détails

Origin ID

88830-5;

UMLS CUI

C4696091;

Has component
- Immunogenicity [LOINC component]
Has scale
- Nar [LOINC scale]
Has system
- FDA package insert [LOINC System]
- ^FDA package insert [LOINC System]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients